Fennec Pharmaceuticals is a specialty pharmaceutical company focused on treatments that protect cancer patients from the side effects of chemotherapy. Its main product is an injectable medicine given to children receiving cisplatin-based chemotherapy to reduce the risk of hearing loss caused by the treatment. The company works with hospitals, oncology clinics and healthcare providers that care for paediatric cancer patients. Fennec is based in Research Triangle Park in North Carolina, in the United States.
The shares are listed on the Toronto Exchange in Canada under the code FRX, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #480 of 868 on the Toronto Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Canada yet.
TrendStrong
76/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average14.3%
From 52-week high-18.4%
MomentumFair
67/100
Typical recent returns for this exchange.
See the numbers →
3-month return-3.5%
6-month return69.2%
12-month, skipping last month24.7%
Risk (lower is better)Weak
32/100
Volatile, with deep drawdowns.
See the numbers →
Volatility (1 year)66.1%
Worst drawdown (1 year)-36.1%
LiquidityWeak
5/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M CAD
Zero-volume days41.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Canada when fundamentals data for this market is added. All Canada stocks.
52-wk range 7.59 – 17.64Daily closes, split-adjusted
Signals
50-day average15.80
200-day average12.58
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.36
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
14.52
Bearish
EMA 10
14.53
Bearish
SMA 20
14.83
Bearish
EMA 20
14.87
Bearish
SMA 50
15.80
Bearish
EMA 50
15.14
Bearish
SMA 100
14.88
Bearish
EMA 100
14.54
Bearish
SMA 200
12.58
Bullish
EMA 200
13.39
Bullish
Oscillators (daily)
RSI (14)
41.63
Neutral
MACD (12, 26)
-0.41
Bearish
Momentum (12)
-6.80
Bearish
Stochastic %K (14)
41.99
Neutral
Williams %R (14)
-58.01
Neutral
CCI (20)
-98.53
Neutral
Pivot points (classic, last session)
S3
14.38
S2
14.38
S1
14.38
Pivot
14.38
R1
14.38
R2
14.38
R3
14.38
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CAD. Educational only, not financial advice.
